Critical Materials Group raises $10.3M to decentralize U.S. explosives production

Why it matters

U.S. munitions output is constrained by concentrated plants, aging equipment and a thin skilled workforce. CMG is betting smaller automated lines can add capacity faster.

Kevin Capozzoli and Travis Swanson have raised $10.3 million in seed funding for Critical Materials Group, their attempt to add smaller, automated production lines to a U.S. explosives supply chain built around a limited number of aging facilities.

The Austin-based manufacturer announced the financing on September 2nd. Overmatch Ventures led the round, with Victory Six Advisors and Fulcrum Ventures participating. CMG plans to spend the money on engineering and operations hires, regulatory work, facility commissioning and development of its modular manufacturing platform.

Capozzoli brings the customer's view of the bottleneck. He spent roughly 25 years in the U.S. Army, including service as an infantry officer and Special Forces operator, before becoming chief strategy officer and later president and chief strategy officer at Mach Industries. He left that defense manufacturer in March 2025 and co-founded CMG later that year.

Swanson brings the chemistry and production background. He founded Rocky Mountain Scientific Laboratory in 2009 and built it around energetic-material synthesis, manufacturing, testing and related national-security research. RMSL operates chemistry and engineering laboratories as well as private explosive and ballistic testing ranges.

Overmatch General Partner Morgan Hitzig said those complementary backgrounds drove the investment. Overmatch's portfolio includes defense, space and industrial-technology businesses, and its website describes an early-stage strategy centered on roughly 25 investments with an average check of $2 million.

A production network instead of another megafactory

CMG's initial product focus is C-4, a plastic explosive used in military demolition. The broader plan is a set of modular, automation-ready systems for explosives, propellants and other energetic materials used in munitions.

CMG is positioning those systems as added capacity for established manufacturers, defense primes and government-owned, contractor-operated plants. That approach gives Capozzoli and Swanson a path into the market without asking the Pentagon to abandon qualified processes or replace existing facilities. "CMG was built to add capacity to that ecosystem," Capozzoli said in the funding announcement.

The distinction matters in defense manufacturing, where qualifying a new supplier can take longer than constructing the equipment. Explosive production also carries safety, security and regulatory demands that make the usual venture playbook of shipping early and correcting later unusable.

When CMG came out of stealth earlier in 2026, Capozzoli described a semi-automated C-4 process designed to progress toward full automation. He said CMG wanted to decentralize production and increase output without displacing incumbent suppliers. Earlier reporting also identified an unnamed foreign-government contract, though CMG has not published its value.

That strategy addresses a documented industrial problem. A 2023 Army Science Board study found that more than 50 mergers and acquisitions had left five prime contractors controlling the defense munitions market. The study counted more than 100 single points of failure across the supply chain and described facilities with outdated equipment, limited robotics and workforces that cannot be expanded quickly.

The labor constraint is especially severe in energetics. The Army study estimated that an average munitions production worker needs two years to become effective, while an energetics worker can require seven years. Automated processes could reduce dependence on scarce manual expertise, but CMG has not published production-volume, cost or safety data that would establish how its system performs against existing lines.

The financing has one unresolved number

The $10.3 million announcement does not fully match CMG's public securities filing. An SEC Form D filed on August 6th reported that CMG had sold $7,795,577 in equity to 15 investors under Rule 506(b), with the first sale occurring on July 27th. The filing listed no remaining securities to be sold under that offering.

The filing could represent part of the seed round or a separate component of the financing. The public documents do not reconcile the roughly $2.5 million difference. CMG also did not publish a valuation or total funding figure.

For a manufacturer founded in 2025, the practical value of the round will depend less on the valuation than on whether it carries CMG through qualification and commissioning. The September 2nd announcement says CMG has current commitments across a contract portfolio, but it does not quantify those commitments, identify customers or provide production volumes.

Commissioning is the next test

CMG's operating timeline remains the central execution question. Reporting from earlier in 2026 said a bootstrapped plant was expected to come online within months, with deliveries planned for the summer. The latest announcement says the seed round will accelerate facility commissioning, indicating that CMG is still working toward that milestone.

The funding gives Capozzoli and Swanson more room to complete the regulatory and engineering work that sits between a laboratory process and repeatable military production. It also gives Overmatch a stake in an upstream layer of defense technology that attracts less attention than drones, autonomous vessels or missile systems, even though each depends on a functioning supply of energetics.

Capozzoli's bet is that the Pentagon's industrial-base problem can be attacked one production node at a time. Swanson's background gives CMG the technical foundation to attempt it. The next proof will come from commissioned capacity and deliveries, where a modular manufacturing thesis becomes an operating factory.